Persona Biomed
Persona Biomed, Inc. is a clinical-stage global biotech company founded in 2015 that accelerates the adoption of Precision Medicine molecular diagnostic healthcare practices. The company develops and commercializes proprietary diagnostic and pharmaceutical laboratory technologies serving clinical physicians and the broader medical community to improve patient outcomes. It holds one patent with three more applications and various intellectual property trademarks. Persona Biomed operates through multiple groups including research and product development, CLIA-certified testing laboratory operations, education services for continuing medical education, and digital product development including AI algorithms and cloud-based platforms. The company has a presence in the United States, Europe (through Persona Biomed Spain SL), and is pursuing associates in South and Central America. It is transitioning from a research-focused entity to a commercialized medical technology products and services company.
Persona Biomed
Persona Biomed, Inc. is a clinical-stage global biotech company founded in 2015 that accelerates the adoption of Precision Medicine molecular diagnostic healthcare practices. The company develops and commercializes proprietary diagnostic and pharmaceutical laboratory technologies serving clinical physicians and the broader medical community to improve patient outcomes. It holds one patent with three more applications and various intellectual property trademarks. Persona Biomed operates through multiple groups including research and product development, CLIA-certified testing laboratory operations, education services for continuing medical education, and digital product development including AI algorithms and cloud-based platforms. The company has a presence in the United States, Europe (through Persona Biomed Spain SL), and is pursuing associates in South and Central America. It is transitioning from a research-focused entity to a commercialized medical technology products and services company.